133 related articles for article (PubMed ID: 37355004)
1. The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Amminger GP; Rice S; Davey CG; Quinn AL; Hermens DF; Zmicerevska N; Nichles A; Hickie I; Incerti L; Weller A; Joseph S; Hilton Z; Pugh C; Rayner M; Reid N; Ratheesh A; Yung AR; Yuen HP; Mackinnon A; Hetrick S; Parker A; Street R; Berger M; Berk M; McGorry PD; Lin A
Biol Psychiatry; 2024 Mar; 95(5):426-433. PubMed ID: 37355004
[TBL] [Abstract][Full Text] [Related]
2. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
[No Abstract] [Full Text] [Related]
3. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.
Rice SM; Hickie IB; Yung AR; Mackinnon A; Berk M; Davey C; Hermens DF; Hetrick SE; Parker AG; Schäfer MR; McGorry PD; Amminger GP
Early Interv Psychiatry; 2016 Aug; 10(4):290-9. PubMed ID: 25130262
[TBL] [Abstract][Full Text] [Related]
4. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
Lespérance F; Frasure-Smith N; St-André E; Turecki G; Lespérance P; Wisniewski SR
J Clin Psychiatry; 2011 Aug; 72(8):1054-62. PubMed ID: 20584525
[TBL] [Abstract][Full Text] [Related]
6. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.
Danthiir V; Burns NR; Nettelbeck T; Wilson C; Wittert G
Nutr J; 2011 Oct; 10():117. PubMed ID: 22011460
[TBL] [Abstract][Full Text] [Related]
7. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
Park Y; Park YS; Kim SH; Oh DH; Park YC
Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
[TBL] [Abstract][Full Text] [Related]
8. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
9. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
13. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
Mozaffarian D; Marchioli R; Macchia A; Silletta MG; Ferrazzi P; Gardner TJ; Latini R; Libby P; Lombardi F; O'Gara PT; Page RL; Tavazzi L; Tognoni G;
JAMA; 2012 Nov; 308(19):2001-11. PubMed ID: 23128104
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids for depression in adults.
Appleton KM; Voyias PD; Sallis HM; Dawson S; Ness AR; Churchill R; Perry R
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004692. PubMed ID: 34817851
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids for depression in adults.
Appleton KM; Sallis HM; Perry R; Ness AR; Churchill R
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004692. PubMed ID: 26537796
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
Pawełczyk T; Grancow-Grabka M; Kotlicka-Antczak M; Trafalska E; Pawełczyk A
J Psychiatr Res; 2016 Feb; 73():34-44. PubMed ID: 26679763
[TBL] [Abstract][Full Text] [Related]
18. Effects of marine-derived and plant-derived omega-3 polyunsaturated fatty acids on erythrocyte fatty acid composition in type 2 diabetic patients.
Liu H; Wang F; Liu X; Xie Y; Xia H; Wang S; Sun G
Lipids Health Dis; 2022 Feb; 21(1):20. PubMed ID: 35144649
[TBL] [Abstract][Full Text] [Related]
19. Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EY; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
JAMA Psychiatry; 2017 Jan; 74(1):19-27. PubMed ID: 27893018
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.
Dangour AD; Allen E; Elbourne D; Fasey N; Fletcher AE; Hardy P; Holder GE; Knight R; Letley L; Richards M; Uauy R
Am J Clin Nutr; 2010 Jun; 91(6):1725-32. PubMed ID: 20410089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
